{
      "Rank": 432,
      "Acronym": [
            "SCA"
      ],
      "AgreementOtherDetails": [],
      "AgreementPISponsorEmployee": [],
      "AgreementRestrictionType": [],
      "AgreementRestrictiveAgreement": [],
      "ArmGroupDescription": [
            "Ten patients in the group only receive nerve functional evaluation and electrophysiology examination before and 1,3,6,12 months after recruit. They will not accept cell therapy.",
            "10 patients in the group accept stem cell transplantation."
      ],
      "ArmGroupInterventionName": [
            "Other: stem cell transplantation"
      ],
      "ArmGroupLabel": [
            "Control group",
            "Stem cell transplantation"
      ],
      "ArmGroupType": [
            "No Intervention",
            "Experimental"
      ],
      "AvailIPDComment": [],
      "AvailIPDId": [],
      "AvailIPDType": [],
      "AvailIPDURL": [],
      "BaselineCategoryTitle": [],
      "BaselineClassDenomCountGroupId": [],
      "NCTId": [
            "NCT01489267"
      ],
      "BaselineClassDenomCountValue": [],
      "BaselineClassDenomUnits": [],
      "BaselineClassTitle": [],
      "BaselineDenomCountGroupId": [],
      "BaselineDenomCountValue": [],
      "BaselineDenomUnits": [],
      "BaselineGroupDescription": [],
      "BaselineGroupId": [],
      "BaselineGroupTitle": [],
      "BaselineMeasureCalculatePct": [],
      "BaselineMeasureDenomCountGroupId": [],
      "BaselineMeasureDenomCountValue": [],
      "BaselineMeasureDenomUnits": [],
      "BaselineMeasureDenomUnitsSelected": [],
      "BaselineMeasureDescription": [],
      "BaselineMeasureDispersionType": [],
      "BaselineMeasureParamType": [],
      "BaselineMeasurePopulationDescription": [],
      "BaselineMeasureTitle": [],
      "BaselineMeasureUnitOfMeasure": [],
      "BaselineMeasurementComment": [],
      "BaselineMeasurementGroupId": [],
      "BaselineMeasurementLowerLimit": [],
      "BaselineMeasurementSpread": [],
      "BaselineMeasurementUpperLimit": [],
      "BaselineMeasurementValue": [],
      "BaselinePopulationDescription": [],
      "BaselineTypeUnitsAnalyzed": [],
      "BioSpecDescription": [],
      "BioSpecRetention": [],
      "BriefSummary": [
            "Hereditary cerebellar ataxia is a type of autosomal dominant genetic disease, lesions mainly involving the cerebellum, but the spinal cord and cranial nerves may also be some involvement. A total of 20 molecularly diagnosed SCA1 patients divided in two groups. One group accepted for the treatment of stem cell transplantation,the other group will be the control. Purpose of this project to prove that allogeneic umbilical cord mesenchymal stem cells are applied to clinical safely, and in the treatment of hereditary cerebellar ataxia is valid."
      ],
      "BriefTitle": [
            "A New Method to Treat Hereditary Cerebellar Ataxia - Umbilical Cord Mesenchymal Stem Cells Transplantation"
      ],
      "CentralContactEMail": [],
      "CentralContactName": [],
      "CentralContactPhone": [],
      "CentralContactPhoneExt": [],
      "CentralContactRole": [],
      "CollaboratorClass": [],
      "CollaboratorName": [],
      "CompletionDate": [
            "July 2014"
      ],
      "CompletionDateType": [
            "Anticipated"
      ],
      "Condition": [
            "Hereditary Cerebellar Ataxia."
      ],
      "ConditionAncestorId": [
            "D000020820",
            "D000009461",
            "D000009422",
            "D000002526",
            "D000001927",
            "D000002493",
            "D000013118",
            "D000020271",
            "D000019636",
            "D000030342"
      ],
      "ConditionAncestorTerm": [
            "Dyskinesias",
            "Neurologic Manifestations",
            "Nervous System Diseases",
            "Cerebellar Diseases",
            "Brain Diseases",
            "Central Nervous System Diseases",
            "Spinal Cord Diseases",
            "Heredodegenerative Disorders, Nervous System",
            "Neurodegenerative Diseases",
            "Genetic Diseases, Inborn"
      ],
      "ConditionBrowseBranchAbbrev": [
            "BC10",
            "BC23",
            "All",
            "BC16",
            "Rare"
      ],
      "ConditionBrowseBranchName": [
            "Nervous System Diseases",
            "Symptoms and General Pathology",
            "All Conditions",
            "Diseases and Abnormalities at or Before Birth",
            "Rare Diseases"
      ],
      "ConditionBrowseLeafAsFound": [
            "Cerebellar Ataxia",
            "Cerebellar Ataxia",
            "Hereditary Cerebellar Ataxia"
      ],
      "ConditionBrowseLeafId": [
            "M3717",
            "M4925",
            "M21663",
            "M15081",
            "M21727",
            "M11556",
            "M4927",
            "M4356",
            "M4894",
            "M15067",
            "M21245",
            "M20711",
            "M22839",
            "T5352"
      ],
      "ConditionBrowseLeafName": [
            "Ataxia",
            "Cerebellar Ataxia",
            "Spinocerebellar Ataxias",
            "Spinocerebellar Degenerations",
            "Dyskinesias",
            "Neurologic Manifestations",
            "Cerebellar Diseases",
            "Brain Diseases",
            "Central Nervous System Diseases",
            "Spinal Cord Diseases",
            "Heredodegenerative Disorders, Nervous System",
            "Neurodegenerative Diseases",
            "Genetic Diseases, Inborn",
            "Spinocerebellar Ataxia"
      ],
      "ConditionBrowseLeafRelevance": [
            "high",
            "high",
            "low",
            "high",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low",
            "low"
      ],
      "ConditionMeshId": [
            "D000001259",
            "D000002524",
            "D000013132"
      ],
      "ConditionMeshTerm": [
            "Ataxia",
            "Cerebellar Ataxia",
            "Spinocerebellar Degenerations"
      ],
      "DelayedPosting": [],
      "DesignAllocation": [
            "Non-Randomized"
      ],
      "DesignInterventionModel": [
            "Single Group Assignment"
      ],
      "DesignInterventionModelDescription": [],
      "DesignMasking": [
            "None (Open Label)"
      ],
      "DesignMaskingDescription": [],
      "DesignObservationalModel": [],
      "DesignPrimaryPurpose": [
            "Treatment"
      ],
      "DesignTimePerspective": [],
      "DesignWhoMasked": [],
      "DetailedDescription": [
            "After admission the patients accepted transplantation would receive physical examination, blood and urine tests, electrocardiogram, electrophysiologic study;evaluation of SCA1 symptoms (balance, walking, dexterity, tremor, memory, mood and concentration),then stem cell therapy\uff1aafter stem cell prepared, the patients accepted 4 times stem cell transplantations through lumbar puncture, the time is 3-5days between two treatments. The control only receive evaluation of SCA1 symptoms ."
      ],
      "DispFirstPostDate": [],
      "DispFirstPostDateType": [],
      "DispFirstSubmitDate": [],
      "DispFirstSubmitQCDate": [],
      "EligibilityCriteria": [
            "Inclusion Criteria:\n\n18-65 years of age\nMolecularly diagnosed SCA1\n\nExclusion Criteria:\n\nCognitively impaired individuals\nSchizophrenics\nPatients with severe kidney and liver disease, epilepsy, heart disease, pulmonary disease, cardiac arrhythmia, diabetes insipidus, leukemia and some other central neural disease (such as Parkinson disease, accidence of brain vascular et al)\nAge less than 18 years, age greater than 65 years"
      ],
      "EnrollmentCount": [
            "20"
      ],
      "EnrollmentType": [
            "Anticipated"
      ],
      "EventGroupDeathsNumAffected": [],
      "EventGroupDeathsNumAtRisk": [],
      "EventGroupDescription": [],
      "EventGroupId": [],
      "EventGroupOtherNumAffected": [],
      "EventGroupOtherNumAtRisk": [],
      "EventGroupSeriousNumAffected": [],
      "EventGroupSeriousNumAtRisk": [],
      "EventGroupTitle": [],
      "EventsDescription": [],
      "EventsFrequencyThreshold": [],
      "EventsTimeFrame": [],
      "ExpAccTypeIndividual": [],
      "ExpAccTypeIntermediate": [],
      "ExpAccTypeTreatment": [],
      "ExpandedAccessNCTId": [],
      "ExpandedAccessStatusForNCTId": [],
      "FDAAA801Violation": [],
      "FlowAchievementComment": [],
      "FlowAchievementGroupId": [],
      "FlowAchievementNumSubjects": [],
      "FlowAchievementNumUnits": [],
      "FlowDropWithdrawComment": [],
      "FlowDropWithdrawType": [],
      "FlowGroupDescription": [],
      "FlowGroupId": [],
      "FlowGroupTitle": [],
      "FlowMilestoneComment": [],
      "FlowMilestoneType": [],
      "FlowPeriodTitle": [],
      "FlowPreAssignmentDetails": [],
      "FlowReasonComment": [],
      "FlowReasonGroupId": [],
      "FlowReasonNumSubjects": [],
      "FlowReasonNumUnits": [],
      "FlowRecruitmentDetails": [],
      "FlowTypeUnitsAnalyzed": [],
      "Gender": [
            "All"
      ],
      "GenderBased": [],
      "GenderDescription": [],
      "HasExpandedAccess": [
            "No"
      ],
      "HealthyVolunteers": [
            "No"
      ],
      "IPDSharing": [],
      "IPDSharingAccessCriteria": [],
      "IPDSharingDescription": [],
      "IPDSharingInfoType": [],
      "IPDSharingTimeFrame": [],
      "IPDSharingURL": [],
      "InterventionAncestorId": [],
      "InterventionAncestorTerm": [],
      "InterventionArmGroupLabel": [
            "Stem cell transplantation"
      ],
      "InterventionBrowseBranchAbbrev": [],
      "InterventionBrowseBranchName": [],
      "InterventionBrowseLeafAsFound": [],
      "InterventionBrowseLeafId": [],
      "InterventionBrowseLeafName": [],
      "InterventionBrowseLeafRelevance": [],
      "InterventionDescription": [
            "The patients accepted 4 times stem cell transplantations through lumbar puncture, the time is 3-5days between two treatments and the dose is about 2 ml(including 1\u00d710'7 cells)."
      ],
      "InterventionMeshId": [],
      "InterventionMeshTerm": [],
      "InterventionName": [
            "stem cell transplantation"
      ],
      "InterventionOtherName": [
            "Cell therapy."
      ],
      "InterventionType": [
            "Other"
      ],
      "IsFDARegulatedDevice": [],
      "IsFDARegulatedDrug": [],
      "IsPPSD": [],
      "IsUSExport": [],
      "IsUnapprovedDevice": [],
      "Keyword": [
            "cerebellar ataxia",
            "hereditary disease",
            "stem cell"
      ],
      "LargeDocDate": [],
      "LargeDocFilename": [],
      "LargeDocHasICF": [],
      "LargeDocHasProtocol": [],
      "LargeDocHasSAP": [],
      "LargeDocLabel": [],
      "LargeDocTypeAbbrev": [],
      "LargeDocUploadDate": [],
      "LastKnownStatus": [
            "Enrolling by invitation"
      ],
      "LastUpdatePostDate": [
            "June 20, 2012"
      ],
      "LastUpdatePostDateType": [
            "Estimate"
      ],
      "LastUpdateSubmitDate": [
            "June 18, 2012"
      ],
      "LeadSponsorClass": [
            "OTHER"
      ],
      "LeadSponsorName": [
            "General Hospital of Chinese Armed Police Forces"
      ],
      "LimitationsAndCaveatsDescription": [],
      "LocationCity": [
            "Beijing"
      ],
      "LocationContactEMail": [],
      "LocationContactName": [],
      "LocationContactPhone": [],
      "LocationContactPhoneExt": [],
      "LocationContactRole": [],
      "LocationCountry": [
            "China"
      ],
      "LocationFacility": [
            "Yihua An"
      ],
      "LocationState": [],
      "LocationStatus": [],
      "LocationZip": [],
      "MaximumAge": [
            "65 Years"
      ],
      "MinimumAge": [
            "18 Years"
      ],
      "NCTIdAlias": [],
      "OfficialTitle": [
            "The Safety and Efficacy of Umbilical Cord Mesenchymal Stem Cells Transplantation in Hereditary Cerebellar Ataxia Patients"
      ],
      "OrgClass": [
            "OTHER"
      ],
      "OrgFullName": [
            "General Hospital of Chinese Armed Police Forces"
      ],
      "OrgStudyId": [
            "20111031SCA"
      ],
      "OrgStudyIdDomain": [],
      "OrgStudyIdLink": [],
      "OrgStudyIdType": [],
      "OtherEventAssessmentType": [],
      "OtherEventNotes": [],
      "OtherEventOrganSystem": [],
      "OtherEventSourceVocabulary": [],
      "OtherEventStatsGroupId": [],
      "OtherEventStatsNumAffected": [],
      "OtherEventStatsNumAtRisk": [],
      "OtherEventStatsNumEvents": [],
      "OtherEventTerm": [],
      "OtherOutcomeDescription": [],
      "OtherOutcomeMeasure": [],
      "OtherOutcomeTimeFrame": [],
      "OutcomeAnalysisCILowerLimit": [],
      "OutcomeAnalysisCILowerLimitComment": [],
      "OutcomeAnalysisCINumSides": [],
      "OutcomeAnalysisCIPctValue": [],
      "OutcomeAnalysisCIUpperLimit": [],
      "OutcomeAnalysisCIUpperLimitComment": [],
      "OutcomeAnalysisDispersionType": [],
      "OutcomeAnalysisDispersionValue": [],
      "OutcomeAnalysisEstimateComment": [],
      "OutcomeAnalysisGroupDescription": [],
      "OutcomeAnalysisGroupId": [],
      "OutcomeAnalysisNonInferiorityComment": [],
      "OutcomeAnalysisNonInferiorityType": [],
      "OutcomeAnalysisOtherAnalysisDescription": [],
      "OutcomeAnalysisPValue": [],
      "OutcomeAnalysisPValueComment": [],
      "OutcomeAnalysisParamType": [],
      "OutcomeAnalysisParamValue": [],
      "OutcomeAnalysisStatisticalComment": [],
      "OutcomeAnalysisStatisticalMethod": [],
      "OutcomeAnalysisTestedNonInferiority": [],
      "OutcomeCategoryTitle": [],
      "OutcomeClassDenomCountGroupId": [],
      "OutcomeClassDenomCountValue": [],
      "OutcomeClassDenomUnits": [],
      "OutcomeClassTitle": [],
      "OutcomeDenomCountGroupId": [],
      "OutcomeDenomCountValue": [],
      "OutcomeDenomUnits": [],
      "OutcomeGroupDescription": [],
      "OutcomeGroupId": [],
      "OutcomeGroupTitle": [],
      "OutcomeMeasureAnticipatedPostingDate": [],
      "OutcomeMeasureCalculatePct": [],
      "OutcomeMeasureDenomUnitsSelected": [],
      "OutcomeMeasureDescription": [],
      "OutcomeMeasureDispersionType": [],
      "OutcomeMeasureParamType": [],
      "OutcomeMeasurePopulationDescription": [],
      "OutcomeMeasureReportingStatus": [],
      "OutcomeMeasureTimeFrame": [],
      "OutcomeMeasureTitle": [],
      "OutcomeMeasureType": [],
      "OutcomeMeasureTypeUnitsAnalyzed": [],
      "OutcomeMeasureUnitOfMeasure": [],
      "OutcomeMeasurementComment": [],
      "OutcomeMeasurementGroupId": [],
      "OutcomeMeasurementLowerLimit": [],
      "OutcomeMeasurementSpread": [],
      "OutcomeMeasurementUpperLimit": [],
      "OutcomeMeasurementValue": [],
      "OverallOfficialAffiliation": [
            "director of neural stem cell transplantation department in general hospital of chinese armed police forces"
      ],
      "OverallOfficialName": [
            "Yihua An, doctor"
      ],
      "OverallOfficialRole": [
            "Study Director"
      ],
      "OverallStatus": [
            "Unknown status"
      ],
      "OversightHasDMC": [
            "Yes"
      ],
      "PatientRegistry": [],
      "Phase": [
            "Phase 2"
      ],
      "PointOfContactEMail": [],
      "PointOfContactOrganization": [],
      "PointOfContactPhone": [],
      "PointOfContactPhoneExt": [],
      "PointOfContactTitle": [],
      "PrimaryCompletionDate": [
            "July 2013"
      ],
      "PrimaryCompletionDateType": [
            "Anticipated"
      ],
      "PrimaryOutcomeDescription": [
            "white blood cell\u3001neutrophilic granulocyte\u3001leukomonocyte\uff1bglutamic pyruvic transaminase(GPT)\u3001glutamic oxalacetic transaminase\u3001lactate dehydrogenase(LDH)\u3001;hydroxybutyrate dehydrogenase(HBDH)\u3001phosphocreatine kinase(CK)\uff1bacidum uricum(UA)\u3001creatinine(Cr)\u3001\u03b11- microglobulin\u3001\u03b22- microglobulin\uff1blymphotoxin(LCT). Tumor markers(AFP,CEA,CA125,CA15-3,CA19-9,CA72-4CY21-1,NSE) ,Lymphocytes classification",
            "Timed-up-and-go test ,5 minutes down-and-up test\nICARS score\nModified Falls Efficacy Scale\nBerg balance assessment\n\nTremor Rating Scale:\n\nPart A - Tremor location/severity rating\nPart B -Handwriting and drawings\nPart C - Functional disabilities resulting from tremor\nQuestionnaires related to sleep, depression (Beck Depression Inventory) (BDI), alertness (Computerized Continuous Performing Tasks) and memory (Mini Mental State Examination)",
            "white blood cell\u3001neutrophilic granulocyte\u3001leukomonocyte\uff1bglutamic pyruvic transaminase(GPT)\u3001glutamic oxalacetic transaminase\u3001lactate dehydrogenase(LDH)\u3001;hydroxybutyrate dehydrogenase(HBDH)\u3001phosphocreatine kinase(CK)\uff1bacidum uricum(UA)\u3001creatinine(Cr)\u3001\u03b11- microglobulin\u3001\u03b22- microglobulin\uff1blymphotoxin(LCT). Tumor markers(AFP,CEA,CA125,CA15-3,CA19-9,CA72-4CY21-1,NSE) ,Lymphocytes classification",
            "white blood cell\u3001neutrophilic granulocyte\u3001leukomonocyte\uff1bglutamic pyruvic transaminase(GPT)\u3001glutamic oxalacetic transaminase\u3001lactate dehydrogenase(LDH)\u3001;hydroxybutyrate dehydrogenase(HBDH)\u3001phosphocreatine kinase(CK)\uff1bacidum uricum(UA)\u3001creatinine(Cr)\u3001\u03b11- microglobulin\u3001\u03b22- microglobulin\uff1blymphotoxin(LCT). Tumor markers(AFP,CEA,CA125,CA15-3,CA19-9,CA72-4CY21-1,NSE) ,Lymphocytes classification",
            "white blood cell\u3001neutrophilic granulocyte\u3001leukomonocyte\uff1bglutamic pyruvic transaminase(GPT)\u3001glutamic oxalacetic transaminase\u3001lactate dehydrogenase(LDH)\u3001;hydroxybutyrate dehydrogenase(HBDH)\u3001phosphocreatine kinase(CK)\uff1bacidum uricum(UA)\u3001creatinine(Cr)\u3001\u03b11- microglobulin\u3001\u03b22- microglobulin\uff1blymphotoxin(LCT). Tumor markers(AFP,CEA,CA125,CA15-3,CA19-9,CA72-4CY21-1,NSE) ,Lymphocytes classification",
            "white blood cell\u3001neutrophilic granulocyte\u3001leukomonocyte\uff1bglutamic pyruvic transaminase(GPT)\u3001glutamic oxalacetic transaminase\u3001lactate dehydrogenase(LDH)\u3001;hydroxybutyrate dehydrogenase(HBDH)\u3001phosphocreatine kinase(CK)\uff1bacidum uricum(UA)\u3001creatinine(Cr)\u3001\u03b11- microglobulin\u3001\u03b22- microglobulin\uff1blymphotoxin(LCT). Tumor markers(AFP,CEA,CA125,CA15-3,CA19-9,CA72-4CY21-1,NSE) ,Lymphocytes classification",
            "Timed-up-and-go test ,5 minutes down-and-up test\nICARS score\nModified Falls Efficacy Scale\nBerg balance assessment\n\nTremor Rating Scale:\n\nPart A - Tremor location/severity rating\nPart B -Handwriting and drawings\nPart C - Functional disabilities resulting from tremor\nQuestionnaires related to sleep, depression (Beck Depression Inventory) (BDI), alertness (Computerized Continuous Performing Tasks) and memory (Mini Mental State Examination)",
            "Timed-up-and-go test ,5 minutes down-and-up test\nICARS score\nModified Falls Efficacy Scale\nBerg balance assessment\n\nTremor Rating Scale:\n\nPart A - Tremor location/severity rating\nPart B -Handwriting and drawings\nPart C - Functional disabilities resulting from tremor\nQuestionnaires related to sleep, depression (Beck Depression Inventory) (BDI), alertness (Computerized Continuous Performing Tasks) and memory (Mini Mental State Examination)",
            "Timed-up-and-go test ,5 minutes down-and-up test\nICARS score\nModified Falls Efficacy Scale\nBerg balance assessment\n\nTremor Rating Scale:\n\nPart A - Tremor location/severity rating\nPart B -Handwriting and drawings\nPart C - Functional disabilities resulting from tremor\nQuestionnaires related to sleep, depression (Beck Depression Inventory) (BDI), alertness (Computerized Continuous Performing Tasks) and memory (Mini Mental State Examination)",
            "Timed-up-and-go test ,5 minutes down-and-up test\nICARS score\nModified Falls Efficacy Scale\nBerg balance assessment\n\nTremor Rating Scale:\n\nPart A - Tremor location/severity rating\nPart B -Handwriting and drawings\nPart C - Functional disabilities resulting from tremor\nQuestionnaires related to sleep, depression (Beck Depression Inventory) (BDI), alertness (Computerized Continuous Performing Tasks) and memory (Mini Mental State Examination)"
      ],
      "PrimaryOutcomeMeasure": [
            "blood test",
            "Nerve functional evaluation",
            "blood test",
            "blood test",
            "blood test",
            "blood test",
            "Nerve functional evaluation",
            "Nerve functional evaluation",
            "Nerve functional evaluation",
            "Nerve functional evaluation"
      ],
      "PrimaryOutcomeTimeFrame": [
            "within one week before transplantation",
            "within one week before transplantation",
            "1 month after transplantation",
            "3 months after transplantation",
            "6 months after transplantation",
            "12 months after transplantation",
            "1 month after transplantation",
            "3 months after transplantation",
            "6 months after transplantation",
            "12 months after transplantation"
      ],
      "ReferenceCitation": [],
      "ReferencePMID": [],
      "ReferenceType": [],
      "RemovedCountry": [],
      "ResponsiblePartyInvestigatorAffiliation": [],
      "ResponsiblePartyInvestigatorFullName": [],
      "ResponsiblePartyInvestigatorTitle": [],
      "ResponsiblePartyOldNameTitle": [],
      "ResponsiblePartyOldOrganization": [],
      "ResponsiblePartyType": [
            "Sponsor"
      ],
      "ResultsFirstPostDate": [],
      "ResultsFirstPostDateType": [],
      "ResultsFirstPostedQCCommentsDate": [],
      "ResultsFirstPostedQCCommentsDateType": [],
      "ResultsFirstSubmitDate": [],
      "ResultsFirstSubmitQCDate": [],
      "RetractionPMID": [],
      "RetractionSource": [],
      "SamplingMethod": [],
      "SecondaryId": [
            "20111031limin"
      ],
      "SecondaryIdDomain": [
            "neuralstemcell"
      ],
      "SecondaryIdLink": [],
      "SecondaryIdType": [
            "Other Identifier"
      ],
      "SecondaryOutcomeDescription": [
            "proteinum\u3001akaryocyte\u3001\u03b11- microglobulin\u3001\u03b22- microglobulin",
            "somatosensory evoked potential(SEP)\u3001brain stem auditory evoked potential(BAEP)",
            "proteinum\u3001akaryocyte\u3001\u03b11- microglobulin\u3001\u03b22- microglobulin",
            "proteinum\u3001akaryocyte\u3001\u03b11- microglobulin\u3001\u03b22- microglobulin",
            "proteinum\u3001akaryocyte\u3001\u03b11- microglobulin\u3001\u03b22- microglobulin",
            "proteinum\u3001akaryocyte\u3001\u03b11- microglobulin\u3001\u03b22- microglobulin",
            "somatosensory evoked potential(SEP)\u3001brain stem auditory evoked potential(BAEP)",
            "somatosensory evoked potential(SEP)\u3001brain stem auditory evoked potential(BAEP)",
            "somatosensory evoked potential(SEP)\u3001brain stem auditory evoked potential(BAEP)",
            "somatosensory evoked potential(SEP)\u3001brain stem auditory evoked potential(BAEP)"
      ],
      "SecondaryOutcomeMeasure": [
            "Urinal test",
            "Electrophysiology examination",
            "Urinal test",
            "Urinal test",
            "Urinal test",
            "Urinal test",
            "Electrophysiology examination",
            "Electrophysiology examination",
            "Electrophysiology examination",
            "Electrophysiology examination"
      ],
      "SecondaryOutcomeTimeFrame": [
            "within one week before transplantation",
            "within one week before transplantation",
            "1 month after transplantation",
            "3 months after transplantation",
            "6 months after transplantation",
            "12 months after transplantation",
            "1 month after transplantation",
            "3 months after transplantation",
            "6 months after transplantation",
            "12 months after transplantation"
      ],
      "SeeAlsoLinkLabel": [],
      "SeeAlsoLinkURL": [],
      "SeriousEventAssessmentType": [],
      "SeriousEventNotes": [],
      "SeriousEventOrganSystem": [],
      "SeriousEventSourceVocabulary": [],
      "SeriousEventStatsGroupId": [],
      "SeriousEventStatsNumAffected": [],
      "SeriousEventStatsNumAtRisk": [],
      "SeriousEventStatsNumEvents": [],
      "SeriousEventTerm": [],
      "StartDate": [
            "December 2011"
      ],
      "StartDateType": [],
      "StatusVerifiedDate": [
            "June 2012"
      ],
      "StdAge": [
            "Adult",
            "Older Adult"
      ],
      "StudyFirstPostDate": [
            "December 9, 2011"
      ],
      "StudyFirstPostDateType": [
            "Estimate"
      ],
      "StudyFirstSubmitDate": [
            "October 30, 2011"
      ],
      "StudyFirstSubmitQCDate": [
            "December 8, 2011"
      ],
      "StudyPopulation": [],
      "StudyType": [
            "Interventional"
      ],
      "SubmissionMCPReleaseN": [],
      "SubmissionReleaseDate": [],
      "SubmissionResetDate": [],
      "SubmissionUnreleaseDate": [],
      "TargetDuration": [],
      "UnpostedEventDate": [],
      "UnpostedEventType": [],
      "UnpostedResponsibleParty": [],
      "VersionHolder": [
            "October 10, 2022"
      ],
      "WhyStopped": []
}